JP2024533273A5 - - Google Patents
Info
- Publication number
- JP2024533273A5 JP2024533273A5 JP2024514660A JP2024514660A JP2024533273A5 JP 2024533273 A5 JP2024533273 A5 JP 2024533273A5 JP 2024514660 A JP2024514660 A JP 2024514660A JP 2024514660 A JP2024514660 A JP 2024514660A JP 2024533273 A5 JP2024533273 A5 JP 2024533273A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- xaa
- structurally stabilized
- item
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163241722P | 2021-09-08 | 2021-09-08 | |
| US63/241,722 | 2021-09-08 | ||
| PCT/US2022/076114 WO2023039474A1 (en) | 2021-09-08 | 2022-09-08 | Antiviral structurally-stapled sars-cov-2 peptide- cholesterol conjugates and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024533273A JP2024533273A (ja) | 2024-09-12 |
| JP2024533273A5 true JP2024533273A5 (cg-RX-API-DMAC10.html) | 2025-09-16 |
Family
ID=83594405
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024514660A Pending JP2024533273A (ja) | 2021-09-08 | 2022-09-08 | 抗ウイルス性の構造的にステープル化されたSARS-CoV-2ペプチド-コレステロールコンジュゲートおよびその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250084128A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4399220A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2024533273A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20240052851A (cg-RX-API-DMAC10.html) |
| CN (1) | CN118401542A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2022341116A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3231587A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL311151A (cg-RX-API-DMAC10.html) |
| MX (1) | MX2024002824A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2023039474A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120958134A (zh) * | 2023-04-12 | 2025-11-14 | 西湖大学 | 用于抑制冠状病毒的融合脂肽 |
| WO2025147479A1 (en) * | 2024-01-04 | 2025-07-10 | Merck Sharp & Dohme Llc | Viral fusion inhibitors |
| WO2025235945A1 (en) * | 2024-05-10 | 2025-11-13 | Red Queen Therapeutics, Inc. | Methods of treating viral infections using a fusion inhibitor |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5446090A (en) | 1993-11-12 | 1995-08-29 | Shearwater Polymers, Inc. | Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules |
| US20020064546A1 (en) | 1996-09-13 | 2002-05-30 | J. Milton Harris | Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor |
| ES2211033T3 (es) | 1998-01-07 | 2004-07-01 | Debio Recherche Pharmaceutique S.A. | Acrilatos de polietilenglicol heterobifuncionales degradables y geles y conjugados derivados de dichos acrilatos. |
| US6348558B1 (en) | 1999-12-10 | 2002-02-19 | Shearwater Corporation | Hydrolytically degradable polymers and hydrogels made therefrom |
| BR0001870B1 (pt) | 2000-05-29 | 2014-02-25 | Peptídeo, processo de obtenção de peptídeo, formulação compreendendo peptídeo, método de prevenção de crescimento de parasitas, fungos e bactérias, método para inativar a endotoxina de bactérias gram-negativas | |
| CN1223605C (zh) * | 2003-05-16 | 2005-10-19 | 中国科学院微生物研究所 | 抑制sars冠状病毒的多肽药物及其衍生物和其应用 |
| EP1680443B9 (en) | 2003-11-05 | 2014-09-03 | Dana-Farber Cancer Institute, Inc. | Stabilized alpha helical peptides and uses thereof |
| EP2208061B1 (en) | 2007-09-26 | 2017-11-08 | Dana Farber Cancer Institute | Methods and compositions for modulating bcl-2 family polypeptides |
| WO2010060112A1 (en) | 2008-11-24 | 2010-05-27 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles with improved properties |
| EP3549951A3 (en) | 2008-12-09 | 2019-11-20 | Dana Farber Cancer Institute, Inc. | Methods and compositions for specific modulation of mcl-1 |
| EP3698811A1 (en) | 2009-06-18 | 2020-08-26 | Dana Farber Cancer Institute, Inc. | Structured viral peptide compositions and methods of use |
| CA3010713A1 (en) * | 2016-01-07 | 2017-07-13 | Navigen, Inc. | D-peptide inhibitors of hiv entry and methods of use |
| US20190048038A1 (en) | 2016-02-23 | 2019-02-14 | Dana-Farber Cancer Institute, Inc. | Method for generating cell-penetrating stapled peptides that lack nonspecific membrane-lytic properties for therapeutic targeting |
| EP4267166A4 (en) * | 2020-12-22 | 2024-11-27 | The University of Chicago | Blockade of sars-cov-2 infection using hydrocarbon stapled peptides |
-
2022
- 2022-09-08 MX MX2024002824A patent/MX2024002824A/es unknown
- 2022-09-08 CN CN202280074123.2A patent/CN118401542A/zh active Pending
- 2022-09-08 IL IL311151A patent/IL311151A/en unknown
- 2022-09-08 EP EP22785887.5A patent/EP4399220A1/en active Pending
- 2022-09-08 WO PCT/US2022/076114 patent/WO2023039474A1/en not_active Ceased
- 2022-09-08 US US18/689,565 patent/US20250084128A1/en active Pending
- 2022-09-08 JP JP2024514660A patent/JP2024533273A/ja active Pending
- 2022-09-08 KR KR1020247011460A patent/KR20240052851A/ko active Pending
- 2022-09-08 AU AU2022341116A patent/AU2022341116A1/en active Pending
- 2022-09-08 CA CA3231587A patent/CA3231587A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6084207B2 (ja) | 虚血性脳損傷及び疼痛治療用の効率的な神経保護剤としてのpsd−95の高親和性二量体阻害剤 | |
| JP5686825B2 (ja) | メタスチン誘導体およびその用途 | |
| CN1126441A (zh) | 使用聚合物放大维生素b12吸收系统 | |
| CN1200127A (zh) | 新的阿片样肽 | |
| US20120010154A1 (en) | Cytotoxic Conjugates Having Neuropeptide Y Receptor Binding Compound | |
| JP2010189398A (ja) | Pacapのペプチド類似体 | |
| IL240686A (en) | Preparations containing cyclic peptides containing adjacent arginine residues | |
| JPH04506664A (ja) | 治療用ペプチド | |
| TW202140513A (zh) | 人類運鐵蛋白受體結合肽 | |
| JP3178835B2 (ja) | 新規ポリペプチドおよびこれを用いる抗hiv剤 | |
| CN108395471B (zh) | 抑制MERS-CoV感染的多肽 | |
| JPH05504558A (ja) | 合成カルシトニンペプチド | |
| US6897289B1 (en) | Peptide synthesis procedure in solid phase | |
| JPWO1992004374A1 (ja) | 新規ポリペプチドおよびこれを用いる抗hiv剤 | |
| US5387671A (en) | Hexa- and heptapeptide anaphylatoxin-receptor ligands | |
| US5223485A (en) | Anaphylatoxin-receptor ligands | |
| CN1204341A (zh) | 含d-2-烷基色氨酸、能促进生长激素释放的寡肽化合物 | |
| US5079231A (en) | Immunostimulating peptides, a process for their preparation and pharmaceutical compositions containing them | |
| JP6952320B2 (ja) | 新規nk3受容体アゴニスト | |
| JPH0676437B2 (ja) | Grf類似体 | |
| KR100360975B1 (ko) | 위장운동자극활성을가지는폴리펩티드 | |
| JPH10501003A (ja) | 免疫調節作用を有する新規ペプチド | |
| CN109153712B (zh) | Peg化生物活性肽及其用途 | |
| CN1030255C (zh) | 环形生长激素释放因子(grf)类似物的制备方法 | |
| JPS60237098A (ja) | アルギニンバソプレツシン拮抗薬の新規誘導体類 |